• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伊朗库姆省布鲁氏菌病的流行病学特征及其治疗失败和复发的影响因素。

Epidemiological features of brucellosis and factors affecting its treatment failure and relapse in Qom Province, Iran.

机构信息

Neuroscience Research Center, Department of Epidemiology and Biostatistics, Qom University of Medical Sciences, Qom, Iran.

Department of Public Health, Faculty of Health, Qom University of Medical Sciences, Qom, Iran.

出版信息

Ghana Med J. 2021 Sep;55(3):206-212. doi: 10.4314/gmj.v55i3.5.

DOI:10.4314/gmj.v55i3.5
PMID:35950176
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9334947/
Abstract

BACKGROUND

Brucellosis is one of the major health problems in many areas of the world, especially in the Mediterranean and the Middle East regions.

OBJECTIVE

To determine the epidemiological characteristics, clinical signs, and risk factors of relapse rate in patients with brucellosis, Qom Province, Iran.

METHODS

A descriptive-analytic study was conducted on 410 confirmed brucellosis cases in Qom Province, central Iran, from 2015 to 2019, based on epidemiological checklists and according to the Iran Ministry of Health and Medical Education (MOHME). Univariate and multiple logistic regression analyses were conducted using Stata software version 14.

RESULTS

The relapse rate of brucellosis was 6.6% until nine months after starting the treatment, and all recurrent cases were infected by . Based on univariate logistic regression analysis, the delayed treatment and type species of were significant factors affecting the relapse of brucellosis. The relapse rates were 5.4%, 6.2%, and 20.0% in patients whose delayed treatments were <50, 51-150, and >151days, respectively. Based on the multiple logistic regression, it was observed that delayed treatment >50 days increased the rate of relapse more than four times.

CONCLUSION

The delayed initiation of treatment was a significant factor influencing the relapse of brucellosis; therefore, it is necessary to provide enough diagnostic and laboratory facilities, and people need to be educated about the signs and symptoms of the disease.

FUNDING

Funding for this research was provided by the Research and Technology Center of Qom University of Medical Sciences, Qom, Iran.

摘要

背景

布鲁氏菌病是世界许多地区,特别是地中海和中东地区的主要健康问题之一。

目的

确定伊朗库姆省布鲁氏菌病患者的流行病学特征、临床症状和复发率的危险因素。

方法

本研究采用描述性分析方法,对 2015 年至 2019 年期间伊朗中部库姆省 410 例确诊布鲁氏菌病患者进行了研究,依据是流行病学检查表,并根据伊朗卫生部和医学教育部(MOHME)的标准进行。使用 Stata 软件版本 14 进行单变量和多变量逻辑回归分析。

结果

在开始治疗后 9 个月内,布鲁氏菌病的复发率为 6.6%,所有复发病例均由 感染。基于单变量逻辑回归分析,延迟治疗和 种属是影响布鲁氏菌病复发的显著因素。治疗延迟<50、51-150 和>151 天的患者的复发率分别为 5.4%、6.2%和 20.0%。基于多变量逻辑回归,观察到治疗延迟>50 天使复发率增加了四倍以上。

结论

延迟开始治疗是影响布鲁氏菌病复发的一个重要因素;因此,有必要提供足够的诊断和实验室设施,并对疾病的症状和体征进行教育。

资金

本研究的资金由伊朗库姆医科大学研究与技术中心提供。

相似文献

1
Epidemiological features of brucellosis and factors affecting its treatment failure and relapse in Qom Province, Iran.伊朗库姆省布鲁氏菌病的流行病学特征及其治疗失败和复发的影响因素。
Ghana Med J. 2021 Sep;55(3):206-212. doi: 10.4314/gmj.v55i3.5.
2
Epidemiological characteristics of human brucellosis in Hamadan Province during 2009-2015: results from the National Notifiable Diseases Surveillance System.2009-2015 年伊朗哈马丹省人间布鲁氏菌病的流行特征:国家法定传染病监测系统的结果。
Int J Infect Dis. 2017 Aug;61:56-61. doi: 10.1016/j.ijid.2017.06.002. Epub 2017 Jun 7.
3
Epidemiology of brucellosis in Iran: A comprehensive systematic review and meta-analysis study.伊朗布鲁氏菌病的流行病学:一项全面的系统评价和荟萃分析研究。
Microb Pathog. 2017 Aug;109:239-247. doi: 10.1016/j.micpath.2017.06.005. Epub 2017 Jun 7.
4
Epidemiological, Risk Factors, Clinical, and Laboratory Features of Brucellosis in the Southwest of Iran within 2009-2015.2009 - 2015年伊朗西南部布鲁氏菌病的流行病学、危险因素、临床及实验室特征
Int J Prev Med. 2019 Jun 12;10:108. doi: 10.4103/ijpvm.IJPVM_14_18. eCollection 2019.
5
Risk Factors for Relapse of Human Brucellosis.人类布鲁氏菌病复发的危险因素。
Glob J Health Sci. 2015 Nov 3;8(7):77-82. doi: 10.5539/gjhs.v8n7p77.
6
Risk factors for human brucellosis in Iran: a case-control study.伊朗人间布鲁氏菌病的危险因素:一项病例对照研究。
Int J Infect Dis. 2008 Mar;12(2):157-61. doi: 10.1016/j.ijid.2007.04.019. Epub 2007 Aug 14.
7
Brucella melitensis infection in dog: a critical issue in the control of brucellosis in ruminant farms.犬布鲁氏菌感染:反刍动物养殖场布鲁氏菌病控制的关键问题。
Comp Immunol Microbiol Infect Dis. 2020 Dec;73:101554. doi: 10.1016/j.cimid.2020.101554. Epub 2020 Sep 17.
8
Epidemiological features of human brucellosis in central Iran, 2006-2011.伊朗中部地区 2006-2011 年人间布鲁氏菌病的流行病学特征。
Public Health. 2012 Dec;126(12):1058-62. doi: 10.1016/j.puhe.2012.07.001. Epub 2012 Aug 11.
9
Establishment of brucellosis relapse and complications registry: a study protocol.布鲁氏菌病复发和并发症登记建立:研究方案。
J Prev Med Hyg. 2021 Jul 30;62(2):E496-E500. doi: 10.15167/2421-4248/jpmh2021.62.2.1422. eCollection 2021 Jun.
10
Epidemiological and clinical features of Brucella arthritis in 24 children.24例儿童布鲁氏菌关节炎的流行病学及临床特征
Ann Saudi Med. 2011 May-Jun;31(3):270-3. doi: 10.4103/0256-4947.81543.

引用本文的文献

1
Brucellosis relapse: Rate, patient characteristics, and clinical outcomes in an endemic region.布鲁氏菌病复发:地方病流行地区的复发率、患者特征及临床结局
PLoS Negl Trop Dis. 2025 Jul 7;19(7):e0013270. doi: 10.1371/journal.pntd.0013270. eCollection 2025 Jul.
2
What Could Lead to the Production of Anti-Rheumatoid Antibodies in Patients with Brucellosis Spondylodiscitis: Possible Causes.布鲁氏菌性脊椎间盘炎患者产生抗类风湿抗体的原因:可能病因
Med J Islam Repub Iran. 2024 Aug 5;38:89. doi: 10.47176/mjiri.38.89. eCollection 2024.
3
Incidence and warning signs for complications of human brucellosis: a multi-center observational study from China.

本文引用的文献

1
An Overview of Brucellosis in Cattle and Humans, and its Serological and Molecular Diagnosis in Control Strategies.牛和人类布鲁氏菌病概述及其在控制策略中的血清学和分子诊断
Trop Med Infect Dis. 2018 Jun 14;3(2):65. doi: 10.3390/tropicalmed3020065.
2
Rifampicin versus streptomycin for brucellosis treatment in humans: A meta-analysis of randomized controlled trials.利福平与链霉素治疗人类布鲁氏菌病的比较:一项随机对照试验的荟萃分析。
PLoS One. 2018 Feb 20;13(2):e0191993. doi: 10.1371/journal.pone.0191993. eCollection 2018.
3
Brucellosis remains a neglected disease in the developing world: a call for interdisciplinary action.
人类布鲁氏菌病并发症的发病率及警示标志:一项来自中国的多中心观察性研究
Infect Dis Poverty. 2024 Feb 20;13(1):18. doi: 10.1186/s40249-024-01186-4.
4
Comparative Study on the Efficacy of Two Perioperative Chemotherapy Regimens for Lumbar Brucellosis.两种围手术期化疗方案治疗腰椎布鲁氏菌病疗效的对比研究。
Drug Des Devel Ther. 2023 Nov 27;17:3523-3536. doi: 10.2147/DDDT.S427477. eCollection 2023.
5
Massive cardiac vegetation and cardiomyopathy in a 23-year-old rancher with brucellosis.一名患有布鲁氏菌病的23岁牧场主出现大量心脏赘生物和心肌病。
Clin Case Rep. 2023 Nov 6;11(11):e8177. doi: 10.1002/ccr3.8177. eCollection 2023 Nov.
6
Peripheral Arthritis and Tenosynovitis in a Patient With Brucellosis.布鲁氏菌病患者的外周关节炎和腱鞘炎
Cureus. 2023 Feb 22;15(2):e35292. doi: 10.7759/cureus.35292. eCollection 2023 Feb.
布鲁氏菌病在发展中国家仍是一种被忽视的疾病:呼吁采取跨学科行动。
BMC Public Health. 2018 Jan 11;18(1):125. doi: 10.1186/s12889-017-5016-y.
4
A review of Brucellosis in Iran: Epidemiology, Risk Factors, Diagnosis, Control, and Prevention.伊朗布鲁氏菌病综述:流行病学、风险因素、诊断、控制与预防
Iran Biomed J. 2017 Nov;21(6):349-59. doi: 10.18869/acadpub.ibj.21.6.349. Epub 2017 Aug 2.
5
Epidemiological characteristics of human brucellosis in Hamadan Province during 2009-2015: results from the National Notifiable Diseases Surveillance System.2009-2015 年伊朗哈马丹省人间布鲁氏菌病的流行特征:国家法定传染病监测系统的结果。
Int J Infect Dis. 2017 Aug;61:56-61. doi: 10.1016/j.ijid.2017.06.002. Epub 2017 Jun 7.
6
Different Clinical Presentations of Brucellosis.布鲁氏菌病的不同临床表现。
Jundishapur J Microbiol. 2016 Apr 9;9(4):e33765. doi: 10.5812/jjm.33765. eCollection 2016 Apr.
7
Risk Factors for Relapse of Human Brucellosis.人类布鲁氏菌病复发的危险因素。
Glob J Health Sci. 2015 Nov 3;8(7):77-82. doi: 10.5539/gjhs.v8n7p77.
8
Systematic review of brucellosis in the Middle East: disease frequency in ruminants and humans and risk factors for human infection.中东地区布鲁氏菌病的系统评价:反刍动物和人类中的疾病发生率及人类感染的危险因素。
Epidemiol Infect. 2016 Mar;144(4):671-85. doi: 10.1017/S0950268815002575. Epub 2015 Oct 28.
9
Human brucellosis: An overview.人类布鲁氏菌病概述
Caspian J Intern Med. 2015 Winter;6(1):46-7.
10
Human brucellosis occurrences in inner mongolia, China: a spatio-temporal distribution and ecological niche modeling approach.中国内蒙古地区人间布鲁氏菌病的发生情况:一种时空分布及生态位建模方法
BMC Infect Dis. 2015 Feb 3;15:36. doi: 10.1186/s12879-015-0763-9.